<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>Rapid Dose Therapeutics Corp. News Releases</title>
		<link>https://feeds.newsfilecorp.com/company/2310</link>
		<description>Latest news from Rapid Dose Therapeutics Corp., as distributed by TMX Newsfile.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Fri, 30 Oct 2026 21:43:06 -0400</lastBuildDate>
		<image>
			<url>https://images.newsfilecorp.com/logos/2310.jpg</url>
			<title>Rapid Dose Therapeutics Corp. News Releases</title>
			<link>https://feeds.newsfilecorp.com/company/2310</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/company/2310"/>
		<item xml:lang="en">
			<title>Rapid Dose Announces Proposed Debt Settlement</title>
			<link>https://www.newsfilecorp.com/release/321905/Rapid-Dose-Announces-Proposed-Debt-Settlement</link>
			<description>Burlington, Ontario--(Newsfile Corp. - October 30, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company") announces that it has agreed with certain of its creditors (the "Creditors") to issue up to an aggregate of 5,000,000 common shares (the "Settlement Shares") to such Creditors in exchange for the cancellation of outstanding accounts payable (the "Shares for Debt Transaction") in the aggregate amount of up to $500,000 (the "Debt") owing to such Creditors....&lt;img src="https://api.newsfilecorp.com/newsinfo/321905/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Fri, 30 Oct 2026 16:19:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/321905</guid>
		</item>
		<item xml:lang="en">
			<title>Rapid Dose Therapeutics Ships QuickStrip(TM) Production Line to Callan JMB's Texas cGMP Facility</title>
			<link>https://www.newsfilecorp.com/release/320149/Rapid-Dose-Therapeutics-Ships-QuickStripTM-Production-Line-to-Callan-JMBs-Texas-cGMP-Facility</link>
			<description>Burlington, Ontario--(Newsfile Corp. - October 21, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company specializing in oral thin-film drug delivery technology, today announced that it has shipped a complete QuickStrip™ production line to Callan JMB Inc. (NASDAQ: CJMB) ("Callan JMB") for planned installation at its cGMP facility in Texas, United States.The shipment advances the collaboration outlined in Callan JMB's November...&lt;img src="https://api.newsfilecorp.com/newsinfo/320149/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Wed, 21 Oct 2026 09:16:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320149</guid>
		</item>
		<item xml:lang="en">
			<title>Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt and Proposed Issuance of Shares as Payment of Accrued Director Fees</title>
			<link>https://www.newsfilecorp.com/release/317389/Rapid-Dose-Announces-Payment-in-Shares-for-Quarterly-Interest-on-Secured-Debt-and-Proposed-Issuance-of-Shares-as-Payment-of-Accrued-Director-Fees</link>
			<description>Burlington, Ontario--(Newsfile Corp. - October 5, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), announced today that pursuant to the terms of its amended and restated secured convertible notes dated December 1, 2025 (the "Notes"), the Company intends to issue common shares ("Common Shares") in satisfaction of the accrued interest payable on September 30, 2026.  The Company expects to issue the Common Shares no later than October 15, 2026.The Notes...&lt;img src="https://api.newsfilecorp.com/newsinfo/317389/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 05 Oct 2026 08:37:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/317389</guid>
		</item>
		<item xml:lang="en">
			<title>Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip(TM) Nicotine Patent, Advancing RDT's Global Commercialization Strategy</title>
			<link>https://www.newsfilecorp.com/release/310585/Rapid-Dose-Therapeutics-and-Aavishkar-Granted-Monolayer-QuickStripTM-Nicotine-Patent-Advancing-RDTs-Global-Commercialization-Strategy</link>
			<description>Second granted nicotine oral-film patent strengthens RDT's intellectual-property portfolio and its collaboration with a global nicotine industry leader, advancing the Company's strategy to build a protected global nicotine delivery platform. Burlington, Ontario--(Newsfile Corp. - August 20, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company specializing in innovative oral thin film drug delivery technology, today announced...&lt;img src="https://api.newsfilecorp.com/newsinfo/310585/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Thu, 20 Aug 2026 08:30:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/310585</guid>
			<atom:subtitle>Second granted nicotine oral-film patent strengthens RDT's intellectual-property portfolio and its collaboration with a global nicotine industry leader, advancing the Company's strategy to build a protected global nicotine delivery platform.</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Rapid Dose Therapeutics (DOSE) (RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN(R) QuickStrip(TM) Curcumin Across Canada</title>
			<link>https://www.newsfilecorp.com/release/306981/Rapid-Dose-Therapeutics-DOSE-RDTCF-and-Bodhi-Health-Expand-Distribution-and-Sales-of-CurcuWINR-QuickStripTM-Curcumin-Across-Canada</link>
			<description>Burlington, Ontario--(Newsfile Corp. - July 28, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("Rapid Dose" or "RDT"), a Canadian biotechnology company, and Ontario-based Bodhi Health Inc. ("Bodhi Health") today announced an expansion of their coordinated distribution, sales and market-development efforts for Bodhi Health Sublingual Curcumin, manufactured using Rapid Dose's proprietary QuickStrip™ oral thin-film technology and the patented CurcuWIN® curcumin formulation, with...&lt;img src="https://api.newsfilecorp.com/newsinfo/306981/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 28 Jul 2026 16:05:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/306981</guid>
		</item>
		<item xml:lang="en">
			<title>Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt</title>
			<link>https://www.newsfilecorp.com/release/304854/Rapid-Dose-Announces-Payment-in-Shares-for-Quarterly-Interest-on-Secured-Debt</link>
			<description>Burlington, Ontario--(Newsfile Corp. - July 10, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secured convertible notes dated December 1, 2025 (the "Notes"), the Company issued common shares ("Common Shares") in satisfaction of the accrued interest payable on June 30, 2026.  The Notes were issued as a result of an extension to the promissory notes that were originally issued by the Company...&lt;img src="https://api.newsfilecorp.com/newsinfo/304854/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Fri, 10 Jul 2026 19:13:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/304854</guid>
		</item>
		<item xml:lang="en">
			<title>Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization</title>
			<link>https://www.newsfilecorp.com/release/304185/Rapid-Dose-Therapeutics-Extends-Strategic-Collaboration-with-Global-Nicotine-Leader-and-Initiating-Saudi-Arabia-Commercialization</link>
			<description>Burlington, Ontario--(Newsfile Corp. - July 7, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company specializing in oral thin film drug delivery technology, is pleased to announce the execution of a Memorandum of Understanding ("MOU") with a global leader in the nicotine products industry, extending the parties' ongoing collaboration surrounding RDT's proprietary QuickStrip™ dissolvable oral nicotine strip technology.The MOU,...&lt;img src="https://api.newsfilecorp.com/newsinfo/304185/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Tue, 07 Jul 2026 07:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/304185</guid>
		</item>
		<item xml:lang="en">
			<title>Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets</title>
			<link>https://www.newsfilecorp.com/release/292167/Rapid-Dose-Therapeutics-DOSE-RDTCF-Advances-Pharmaceutical-Manufacturing-Expansion-with-Burlington-Facility-Upgrades-Targeting-Global-Medical-Markets</link>
			<description>Burlington, Ontario--(Newsfile Corp. - April 13, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company developing oral thin film drug delivery technologies, today announced the initiation of clean room upgrades and facility retrofitting at its Burlington, Ontario manufacturing site, positioning the Company for pharmaceutical expansion, regulatory advancement, and global commercialization opportunities.The upgrade program is...&lt;img src="https://api.newsfilecorp.com/newsinfo/292167/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 13 Apr 2026 09:51:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/292167</guid>
		</item>
		<item xml:lang="en">
			<title>Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt</title>
			<link>https://www.newsfilecorp.com/release/291296/Rapid-Dose-Announces-Payment-in-Shares-for-Quarterly-Interest-on-Secured-Debt</link>
			<description>Burlington, Ontario--(Newsfile Corp. - April 6, 2026) -  Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secured convertible notes dated December 1, 2025 (the "Notes"), the Company intends to issue common shares ("Common Shares") in satisfaction of the accrued interest payable on March 31, 2026.  The Company expects to issue the Common Shares no later than April 15, 2026.The Notes were issued...&lt;img src="https://api.newsfilecorp.com/newsinfo/291296/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 06 Apr 2026 16:30:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/291296</guid>
		</item>
		<item xml:lang="en">
			<title>Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory</title>
			<link>https://www.newsfilecorp.com/release/290053/Rapid-Dose-Therapeutics-Reinforces-Strategic-Strength-and-Global-Growth-Trajectory</link>
			<description>Burlington, Ontario--(Newsfile Corp. - March 26, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology leader specializing in innovative oral thin film drug delivery, is pleased to provide shareholders with a strategic update highlighting its continued execution, operational resilience, and expanding global footprint.In an environment marked by global market volatility and geopolitical uncertainty, RDT is uniquely positioned with a...&lt;img src="https://api.newsfilecorp.com/newsinfo/290053/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Thu, 26 Mar 2026 09:09:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/290053</guid>
		</item>
	</channel>
</rss>
